Over 600,000 cats are treated by veterinarians for serious gastrointestinal distress each year. Gastrointestinal lymphoma is one of the most common and serious malignancies in elderly pets, but the symptoms are challenging to differentiate from less serious disorders, such as inflammatory bowel disease. Currently, diagnosis requires an invasive endoscopic or surgical biopsy, which put the animal under distress and do not always provide conclusive results. Several noninvasive diagnostic tests exist, but have low accuracy due to their reliance on testing peripheral blood.
Geneoscopy has used its platform technology to develop a stool-based, lymphocyte-specific RNA biomarker panel that can accurately differentiate GI lymphoma from other less serious conditions that cause gastrointestinal distress. This diagnostic test will allow for more timely and accurate diagnoses of GI lymphoma. This will limit the number of invasive procedures, enable earlier treatment, and reduce mortality associated with the disease.
Lymphoma is the most commonly diagnosed neoplasm in cats, and gastrointestinal (GI) lymphoma is now the most common anatomic form.
– Compendium Vet
If a pet with GI lymphoma is left untreated, the prognosis is bad and the life expectancy is not more than 2 months.